Flecainide/Modafinil

氟卡尼/莫达非尼

Report date: 2024/02/01 20:01:00

Base Information

Drug NameFlecainide/Modafinil
Drug Alias Name莫达非尼/氟卡尼醋酸盐Flecainide+Modafinil氟卡尼+莫达非尼Fixed-dose combination of modafinil and flecainide acetateModafinil/flecainide +[9] 
ClassificationSmall molecules
Mechanisms of ActionDopamine transporter antagonists
TargetsSodium channel alpha subunitDopamine transporter
Therapy Area/IndicationsNarcolepsySleep Deprivation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumFrance
CombinationsYes ModafinilFlecainide Acetate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheranexusFrench Armed Medical Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheranexus
Active IndicationsN/A
Inactive IndicationsNarcolepsySleep Deprivation

Other Information

ATC CodeN/A
Related LinksN/A